FDA Adverse Event Injury Summary report: N

ISPAN PERFLUOROPROPANE (C3F8) GAS

MDR report key: 15814952 · Received November 17, 2022

Report

Report Number
2518435-2022-00025
Event Type
Injury
Date Received
November 17, 2022
Date of Event
January 8, 2022
Report Date
November 17, 2022
Manufacturer
AIRGAS THERAPEUTICS LLC
Product Code
LPO
UDI-DI
00380657971022
PMA / PMN Number
P900066
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT ORIGINALLY FILED UNDER MFG REPORT NUM 1610287-2022-00040. ALL FUTURE REPORTS WILL BE SUBMITTED UNDER MFG REPORT NUM REFLECTED IN SECTION G.8 OF THIS REPORT. THE C3F8 [PERFLUOROPROPANE (PFP)] GAS TANK WAS NOT RETURNED FOR EVALUATION. A CHECK OF THE BATCH PRODUCTION RECORD FOR LOT SHOWED NO UNUSUAL MANUFACTURING ISSUES. A CHECK OF THE COMPLAINT RECORDS SHOWED SEVEN OTHER COMPLAINTS AGAINST LOTS. A CHECK OF CONFIRMED COMPLAINTS FOR CORNEAL EPITHELIAL INJURY, CORNEAL EDEMA, OR OCULAR HYPERTENSION SHOWED NO COMPLAINTS SINCE THE BEGINNING OF 2015. NO SAMPLE WAS RETURNED FOR EVALUATION. AN ANALYSIS OF THE RETAIN SAMPLE FOR LOTS, SHOWED THAT THE PRODUCT WAS PERFLUOROPROPANE (PFP) AND MET ALL RELEASE CRITERIA. THE ROOT CAUSE CANNOT BE DETERMINED CONCLUSIVELY. MANUFACTURER WILL CONTINUE TO MONITOR DATA FOR EVIDENCE OF ADVERSE TRENDING AND TAKE FURTHER ACTION, AS APPROPRIATE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A CLINICAL STUDY REPORT STATING THAT AFTER USING THE PERFLUOROPROPANE GAS THE PATIENT WAS EXPERIENCED WITH CORNEAL EPITHELIAL INJURY. MEDICAL TREATMENT WAS PROVIDED AND SYMPTOMS WERE RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2786886 ISPAN PERFLUOROPROPANE (C3F8) GAS INTRAOCULAR GAS LPO AIRGAS THERAPEUTICS LLC NA 034914 00380657971022

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention| O